AN ALTERNATIVE SOURCE TO OMEGA-3 FATTY ACIDS: REFINED BUGLOSSOIDES ARVENSIS SEED OIL- A NOVEL THERAPEUTIC AGENT TO ACHIEVE OMEGA BALANCE?

Chronic disease is at an all-time high with over 90% of people eating a Western diet found to be deficient in omega-3 while consuming an excess of proinflammatory omega-6 oils.(1) Marine-derived omega oils have significant consequences for the environment with some experts predicting virtually empty oceans by 2048 forced by fish stocks collapsing. According to experts, there is no way for the global population to meet recommended dietary EPA/DHA intakes from marine sources and other terrestrial sources need to be utilised. Many of our current sources are forced to pass the rate limiting delta-6-desaturase enzyme step to be utilized in the body. Surprisingly, regeneratively grown refined Buglossoides arvensis seed oil, a hedgerow plant, has been found to provide the most diverse array of anti-inflammatory oxylipin precursors from complementary omega 3-6 pathways. Not only is it rich in omega-3 fatty acids, hence its patented name Ahiflower®, it is also especially rich in SDA (up to 21%) which bypasses the rate limiting delta-6-desaturase step. Refined Buglossoides arvensis seed oil also provides recognised anti-inflammatory substrates including ETA, EPA, DPA, DGLA and efficiently biosynthesised DHA. Refined Buglossoides arvensis seed oil is the only vegan, non-GMO dietary oil available with more efficient metabolic conversion and accrual of EPA and DHA biosynthesis than from flax, chia, hemp, sacha inchi, perilla, or echium oils and whilst providing the ALA, SDA, ETA and GLA not provided by algal oils. [ABSTRACT FROM AUTHOR]